Company / Cash per Share
Dare Bioscience, Inc. Cash per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.84
FY2025
5-year range
$0.12 / $2.84
FY2021-FY2025
Trend
+50.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has fluctuated over the past 7 years, ranging from $0.12 in FY2023 to $21.27 in FY2014.
Based on SEC 10-K filings.
2.84 in FY2025 with a 10-year CAGR of +26.4%.
Improved from $0.12 to $2.84 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +90.2%
- 5-Year CAGR
- -
- 10-Year CAGR
- +26.4%
Key checks
Key Insights
- In FY2025, cash per share increased 50.7% year-over-year.
- Peak cash per share was recorded in FY2014.
- Lowest cash per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.23 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.84 | +50.7% |
| FY2024 | $1.88 | +1425.7% |
| FY2023 | $0.12 | -70.1% |
| FY2022 | $0.41 | +105.8% |
| FY2016 | $0.20 | -26.4% |
| FY2015 | $0.27 | -98.7% |
| FY2014 | $21.27 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026